Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side effects.

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

GLP-1 weight loss drugs - such as Wegovy and Mounjaro - may reduce risk of conditions including Alzheimer’s disease and ...

Ozempic and Wegovy are being linked to surprising effects on overall health. A new study finds these drugs may improve heart ...

Dr. Anelyssa D'Abreu, an associate professor of neurology in UVA's School of Medicine who specializes in geriatric neurology, ...